TEVA teams up with Fosun to speed the development of TEV-56278, a novel anti-cancer immunotherapy ta...
Companies say further domestic investment is too risky in such a low-margin and unpredictable busine...
Teva (TEVA) Pharmaceutical and Shanghai Fosun Pharmaceutical announced that the companies, through t...
TEL AVIV, Israel and SHANGHAI, June 16, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd....